{"id":2848,"date":"2024-12-31T12:05:02","date_gmt":"2024-12-31T12:05:02","guid":{"rendered":"https:\/\/medical-article.com\/?p=2848"},"modified":"2024-12-31T12:05:02","modified_gmt":"2024-12-31T12:05:02","slug":"top-10-healthcare-economist-posts-of-2024","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=2848","title":{"rendered":"Top 10 Healthcare Economist posts of 2024"},"content":{"rendered":"

What were the most popular posts on Healthcare Economist<\/a><\/strong> this year? Here are the top 10 in descending order: <\/p>\n

Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices<\/a>The world is relying on the United States to get value-based drug pricing right<\/a>Why is the market design for innovative pharmaceuticals not well understood?<\/a>Requiem for odds ratios?<\/a>Challenges in Conducting Economic Evaluations for Orphan Drugs in Rare Diseases<\/a>Which econometric method should you use for health policy causal inference?<\/a>Does NICE consider real-world data (RWD) for HTA evaluations?<\/a>Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses?<\/a>Daron Acemoglu, Simon Johnson and James Robinson win 2024 Nobel Prize in Economics<\/a>The Carer QALY Trap<\/a><\/p>\n

Other articles high on the popularity list, but which fell just outside the top 10 include: \u201cWhat is HEMA?<\/a>\u201c, \u201cWill ICER\u2019s \u2018shared savings\u2019 approach decrease value-based prices most for the most severe diseases?<\/a>\u201d and \u201cDo Treatment Sequencing \/ Pathways Models Have a Place in Health Technology Assessment?<\/a>\u201c<\/p>\n

If you missed any of these, feel free to take some to review any that sound interesting to you. <\/p>\n

Of note, 2025 will mark my 20th year of blogging <\/strong>nearly every weekday. I started the blog January 19, 2006 with the wholly original post \u201cWelcome!<\/a>\u201d and have written over 5,500 articles since. I look forward to writing posts for this blog for at least another 20 years to come. <\/p>","protected":false},"excerpt":{"rendered":"

What were the most popular posts on Healthcare Economist this year? Here are the top 10 in descending order: Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best PracticesThe world is relying on the United States to get value-based drug pricing rightWhy is the market design for innovative…<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-2848","post","type-post","status-publish","format-standard","hentry","category-articles"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/2848"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2848"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/2848\/revisions"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}